Benzinga's Top Upgrades
December 24, 2013 at 08:44 AM EST
Analysts at Wells Fargo upgraded Allergan (NYSE: AGN ) from “market perform” to “outperform.” The target price range for Allergan has been raised from $99-$100 to $121-$122. Allergan's shares closed at $107.39 yesterday. CRT Capital upgraded Engility Holdings (NYSE: EGL ) from “fairly valued” to “buy.” The target
